Alumnus Gregory Berk, M.D., named Chief Medical Officer and Vice President of Hana Biosciences
School of Medicine grad brings valuable research, clinical experience to biopharmaceutical company
November 2, 2004 | For more information: George Stamatis 216-368-3635
 Hana Biosciences, Inc., a biopharmaceutical company headquartered in South San Francisco, Calif., announced Oct. 21 that Gregory Berk, M.D. has been named chief medical officer and vice president. Berk received an M.D., in 1984 from the Case Western Reserve University School of Medicine.
Berk was most recently medical director for Network of Medical Communications and Research where he provided clinical development strategy consulting for leading global oncology companies. Among other prior positions, he was attending physician, Department of Medicine, New York Presbyterian Hospital and clinical assistant professor of medicine, Weill Medical College, Cornell University, New York. While on the faculty at Cornell, Berk was an investigator in numerous clinical trials, including the Gleevec pivotal trials, Avastin colorectal and breast trials, and several CALGB studies.
“Greg Berk’s experience as a medical oncologist and clinical trial investigator, as well as his collaborations with leading research institutions, will be invaluable as Hana increases the breadth and depth of our oncology pipeline,” said Mark J. Ahn, Ph.D., CEO and president, Hana Biosciences.
Berk holds a B.S. degree (summa cum laude) from Tulane University, New Orleans. He also attended Cambridge University, England. He completed his internship, residency, and fellowship training at The New York Hospital-Cornell Medical Center. Berk is board certified in internal medicine and medical oncology. He is a member of the American Society of Hematology and American Society of Clinical Oncology.
About Hana Biosciences
Hana Biosciences acquires, develops, and commercializes innovative products for the treatment of important unmet medical needs in cancer and immunological diseases. The company is committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture. Additional information on Hana Biosciences can be found at http://www.hanabiosciences.com.
About Case Western Reserve University
Case is among the nation's leading research institutions. Founded in 1826
and shaped by the unique merger of the Case Institute of Technology and Western
Reserve University, Case is distinguished by its strengths in education, research,
service, and experiential learning. Located in Cleveland, Case offers nationally
recognized programs in the Arts and Sciences, Dental Medicine, Engineering,
Law, Management, Medicine, Nursing, and Social Work. http://www.case.edu.
|
